How much does it cost to build a manufacturing plant for atomoxetine (Strattera)?
No specific, public estimate of the manufacturing plant cost for atomoxetine (Strattera) is available in the information provided here. Reports and company filings typically do not break out a “plant cost” figure tied to one product and one site, and the published costs that do exist usually cover broader manufacturing programs rather than atomoxetine alone.
What costs actually drive “plant cost” for a drug like Strattera?
When people ask about manufacturing plant cost, they usually mean the combined cost to design, build, validate, and qualify a facility for pharmaceutical production. For a solid oral prescription drug such as atomoxetine, major cost drivers generally include facility construction and engineering, cleanroom/utility systems, process equipment, quality systems and validation (including process validation and cleaning validation), regulatory readiness, and initial commissioning/qualification.
Can you find atomoxetine (Strattera) site-specific cost numbers in public sources?
Site-specific capex tied to atomoxetine/Strattera alone is rarely disclosed in a way that can be reliably converted into a single “manufacturing plant cost” number. If you’re looking for a number that’s close to what you want, the most realistic public approach is to use:
- Parent-company capital expenditure reports that mention API/finished-dose capacity expansion in general terms, and
- Any project-specific summaries in investor materials (if they exist) that name the site and broad product category, even if they don’t name atomoxetine.
How to estimate it if you need a rough budget figure
If you need a ballpark, analysts typically estimate using comparable pharmaceutical facility build costs (per m²) plus dedicated equipment and validation. Without the size (m²), whether it’s API vs finished dose, the class/complexity of the facility, and the commissioning timeline, any estimate would be guesswork rather than a defensible “atomoxetine plant cost.”
Quick clarifying questions (so the cost estimate can be made more concrete)
1) Do you mean the cost to manufacture the API (atomoxetine) or the finished tablets (Strattera)?
2) Are you asking about a specific company/site, or just an industry-wide estimate?
3) Do you want a budget range (rough estimate) or a fact-based figure from public disclosures?
Sources: none provided in the prompt.